Symbols / /MCL
/MCL Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Real-World Covalent BTK Inhibitor Use Confers Limited Efficacy in R/R MCL - OncLive ue, 13 Jan 2026 08
- Madhav Copper Limited's (NSE:MCL) 48% Share Price Surge Not Quite Adding Up - simplywall.st ue, 30 Dec 2025 08
- Lakers star LeBron James shares workout update weeks after sustaining MCL injury in playoff loss - Yahoo Sports Mon, 23 Jun 2025 07
- Sonrotoclax Displays Activity in BTK Inhibitor–Pretreated R/R MCL - OncLive Mon, 08 Dec 2025 08
- MCL Share Price Today - Madhav Copper Stock Analysis - Equitypandit ue, 30 Dec 2025 04
- Obinutuzumab/Zanubrutinib/Pomalidomide/Venetoclax Quadruplet Is Effective in High-Risk MCL - OncLive Wed, 07 Jan 2026 08
- Coal India surges near 52-week highs: What MCL and SECL listing approval means for your portfolio in 2026 - The Financial Express Wed, 24 Dec 2025 08
- GLPG5101 Yields Rapid Time to Infusion, Durable Responses in R/R NHL, MCL - Targeted Oncology Mon, 08 Dec 2025 08
- Coal India Board's Bold Move: IPOs for MCL & SECL Approved, Stock Surges 3%! - Whalesbook Wed, 24 Dec 2025 08
- Hongkong Land closes 1.2% higher on S$738.7 million MCL Land divestment - The Business Times Fri, 19 Sep 2025 07
- Magellanic Cloud Limited Expands with Strategic Acquisition of Finoux Solutions - scanx.trade ue, 11 Nov 2025 08
- CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL - AJMC Sat, 22 Nov 2025 08
- BTK Inhibitors Lead to Decreased Health Care Resource Utilization in MCL - OncLive Mon, 15 Sep 2025 07
- Frontline Zanubrutinib-Based Therapy Shows High CR Rates in Elderly and High-Risk MCL - OncLive ue, 06 Jan 2026 08
- Acalabrutinib/Rituximab Followed by Brexu-Cel Drives Responses in Untreated High-Risk Mantle Cell Lymphoma - OncLive Mon, 08 Dec 2025 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for /MCL
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|